Related Experiment Video
Updated: Jun 30, 2025

12:03
Viability Assays for Cells in Culture
Published on: January 20, 2014
46.2K
Assessing cell viability with dynamic optical coherence microscopy
Chao J Liu1, Jason T Smith1, Yuanbo Wang1
1Elephas Biosciences Corporation, 1 Erdman Place, Madison, WI 53717, USA.
Biomedical Optics Express
|March 18, 2024
Summary
Dynamic optical coherence microscopy (dOCM) offers a label-free method to assess cell viability. This technique accurately distinguishes live from dead cells in tumors and correlates with metabolic imaging, advancing cancer research and therapy assessment.
Area of Science:
- Biomedical Optics
- Cellular Metabolism Imaging
- Cancer Research
Background:
- Accurate cell viability assessment is crucial across research disciplines.
- Existing optical methods using fluorescent dyes present limitations in reliability and tissue penetration.
- Dynamic optical coherence microscopy (dOCM) offers label-free contrast based on cellular metabolic changes.
Purpose of the Study:
- To compare label-free dOCM contrast with traditional viability dyes.
- To demonstrate dOCM's capability in distinguishing live from dead cells in complex biological samples.
- To establish the correlation between dOCM live contrast and cellular metabolic state.
Main Methods:
- Utilized dynamic optical coherence microscopy (dOCM) for label-free imaging.
- Compared dOCM contrast with standard viability dyes in biological samples.
- Performed metabolic imaging using optical redox ratio in primary mouse liver tissue.
Main Results:
- dOCM successfully distinguished live from dead cells in murine syngeneic tumors, a novel finding.
- A strong correlation was observed between dOCM live contrast and the optical redox ratio in liver tissue.
- Label-free dOCM provides reliable contrast reflecting cellular metabolic status.
Conclusions:
- dOCM is a promising label-free imaging tool for assessing cell viability in research settings.
- This technique can be applied to evaluate the efficacy of various cancer therapies, including immuno-oncology and chemotherapy.
- dOCM offers a new pathway for analyzing live tumor tissues without exogenous labels.

